• Publications
  • Influence
Serum cytokine and soluble cytokine receptor levels in patients with non‐alcoholic steatohepatitis
Abstract: Background: Although the pathogenesis of non‐alcoholic steatohepatitis (NASH) remains poorly understood, proinflammatory cytokines seem to play an important role in the process of NASH. WeExpand
  • 179
  • 8
Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection--association between TGF-beta1 polymorphisms and hepatocellular carcinoma.
BACKGROUND/AIMS In this study, we determined the frequencies of the genotypes associated with the polymorphism of the cytokines genes, and investigated their association with the risk ofExpand
  • 69
  • 6
The des-gamma-carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma.
BACKGROUND Des-gamma-carboxy prothrombin (DCP) has been reported to be an important prognostic factor in patients with hepatocellular carcinoma (HCC). Recently, a monoclonal antibody, 19B7, whichExpand
  • 25
  • 3
Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection—association between TGF-β1 polymorphisms and hepatocellular carcinoma
BACKGROUND/AIMS: In this study, we determined the frequencies of the genotypes associated with the polymorphism of the cytokines genes, and investigated their association with the risk ofExpand
  • 127
  • 2
Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis.
BACKGROUND/AIMS The presence of antibodies to the 210-kDa glycoprotein of the nuclear pore complex (gp210) is highly indicative of primary biliary cirrhosis (PBC). However, the significance ofExpand
  • 98
  • 2
The des‐γ‐carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma
Des‐γ‐carboxy prothrombin (DCP) has been reported to be an important prognostic factor in patients with hepatocellular carcinoma (HCC). Recently, a monoclonal antibody, 19B7, which recognizes the GlaExpand
  • 41
  • 2
Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C
We evaluated the synergistic effect of zinc supplementation on the response to interferon (IFN) therapy in patients with intractable chronic hepatitis C in a pilot study using natural IFN‐α with orExpand
  • 87
  • 1
Differences in prognostic factors according to viral status in patients with hepatocellular carcinoma.
The number and ratio of both HBsAg- and HCV Ab-negative hepatocellular carcinoma (HCC-nonBC) cases have been steadily increasing in Japan. The aim of this study was to examine the frequency ofExpand
  • 16
  • 1
  • PDF
Factors useful in predicting the response to interferon therapy in chronic hepatitis C
To determine how various factors influence the response to interferon (IFN) therapy, we retrospectively studied 157 consecutive Japanese patients with chronic hepatitis C who received variousExpand
  • 59